Skip To Main Content
Betsy McKay on Muck Rack

Betsy McKay

Verified
Atlanta, New York
As seen in: The Wall Street Journal, MSN, MSN Australia, MSN South Africa, The Wall Street Journal (Japan), La Nación (Argentina), The Wall Street Journal (China), Yahoo Finance, MarketWatch, The Toronto Star, Flipboard and
Senior Writer, The Wall Street Journal. I write about public health issues. Please send tips to betsy.mckay@wsj.com.

Get in touch with Betsy

Contact Betsy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Betsy McKay’s Biography

Read Full Bio →

mũ nồi nam <a href="munoixinh.com/mu-beret-nam"> mũ nồi nam </a>

Articles

CDC Expands Cyclospora Outbreak Probe to Four More States

|
By Joseph De Avila Verified, Betsy McKay Verified
| The Wall Street Journal Verified
Outbreak stems from consumption of iceberg lettuce from Taylor Farms, health officials say Updated July 24, 2026 12:29 pm ET The CDC says nearly 100 people have been hospitalized in the cyclospora outbreak. Megan Varner/Bloomberg News Public-health officials are investigating four additional states as part of a multistate cyclospora outbreak linked to iceberg lettuce that they warn could be even broader.
Open in Who Shared Issue with article?

Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss Data

|
By Betsy McKay Verified, Elias Schisgall Verified
| Yahoo Finance Verified
Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide. - Scott Olson/Getty Images Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two Phase 3 trials showing the treatment delivered substantial results.
Open in Who Shared Issue with article?

Federal Officials Investigate Online Ketamine Sellers to Curb At-Home Use

|
By Betsy McKay Verified, Shalini Ramachandran Verified
| The Wall Street Journal Verified
DEA, FDA probing sales that have led to overuse and death An at-home ketamine therapy kit. Calla Kessler for WSJ The federal government is cracking down on companies that provide ketamine for consumers to take at home, as concerns grow about misuse, adverse effects and deaths. The Drug Enforcement Administration has ongoing multiple investigations into “bad actors” prescribing the powerful mind-altering drug online, according to a person familiar with the probes.
Open in Who Shared Issue with article?
See all 789 licensed articles (849 Total)